NeuroMetrix, Inc. Warrants
NUROW
NUROW was delisted on the 26th of May, 2020.
2 hedge funds and large institutions have $401K invested in NeuroMetrix, Inc. Warrants in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
35% less capital invested
Capital invested by funds: $613K → $401K (-$212K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$121 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$24 |
NUROW Hedge Fund Activity: Q3 2016 in Review
2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Warrants (NUROW) for Q3 2016, worth a combined $401K — down 35% from $613K a quarter earlier.
Fund positioning in NUROW was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, adding an estimated $121. The largest seller was UBS Group, cutting an estimated $24.
- 2 institutional investors held NeuroMetrix, Inc. Warrants (NUROW) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $401K of NeuroMetrix, Inc. Warrants stock for Q3 2016, down 35% quarter-over-quarter.
- 0 funds opened new NeuroMetrix, Inc. Warrants positions in Q3 2016 and 0 closed out.
- The largest NeuroMetrix, Inc. Warrants buyer in Q3 2016 was Sabby Management, an estimated $121 added.
- The largest NeuroMetrix, Inc. Warrants seller in Q3 2016 was UBS Group, an estimated $24 sold.
Based on aggregated 13F filings for Q3 2016.